Found: 38
Select item for more details and to access through your institution.
Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 3, p. 443, doi. 10.1007/s00432-014-1583-9
- By:
- Publication type:
- Article
Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 5, p. 737, doi. 10.1007/s00432-009-0712-3
- By:
- Publication type:
- Article
A Phase II Trial of Docetaxel With Bevacizumab as First-line Therapy for HER2-Negative Metastatic Breast Cancer (TORI B01).
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 4, p. 307, doi. 10.3816/CBC.2010.n.040
- By:
- Publication type:
- Article
A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma.
- Published in:
- BJU International, 2011, v. 108, n. 5, p. 679, doi. 10.1111/j.1464-410X.2010.09947.x
- By:
- Publication type:
- Article
Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm.
- Published in:
- BJU International, 2008, v. 102, n. 6, p. 692, doi. 10.1111/j.1464-410X.2008.07660.x
- By:
- Publication type:
- Article
A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancer.
- Published in:
- BJU International, 2007, v. 100, n. 4, p. 765, doi. 10.1111/j.1464-410X.2007.07121.x
- By:
- Publication type:
- Article
Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.
- Published in:
- BJU International, 2007, v. 100, n. 1, p. 21, doi. 10.1111/j.1464-410X.2007.06877.x
- By:
- Publication type:
- Article
Dacomitinib, an Irreversible Pan-ErbB Inhibitor Significantly Abrogates Growth in Head and Neck Cancer Models That Exhibit Low Response to Cetuximab.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056112
- By:
- Publication type:
- Article
Arterial Thromboembolic Events in Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumab.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 16, p. 1232, doi. 10.1093/jnci/djm086
- By:
- Publication type:
- Article
Association of k-ras, b-raf, and p53 Status With the Treatment Effect of Bevacizumab.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 13, p. 981, doi. 10.1093/jnci/dji174
- By:
- Publication type:
- Article
HBI-8000, HUYABIO Lead Clinical Program, Is a Selective Histone Deacetylase Inhibitor With Therapeutic Benefits in Leukemia and in Solid Tumors.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.768685
- By:
- Publication type:
- Article
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.
- Published in:
- Oncogene, 1999, v. 18, n. 44, p. 6050, doi. 10.1038/sj.onc.1202993
- By:
- Publication type:
- Article
Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
- Published in:
- Oncogene, 1999, v. 18, n. 13, p. 2241, doi. 10.1038/sj.onc.1202526
- By:
- Publication type:
- Article
Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen-independent prostate carcinoma.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 4, p. 746, doi. 10.1002/cncr.11956
- By:
- Publication type:
- Article
Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen.
- Published in:
- Cancer (0008543X), 2003, v. 97, p. 2381
- By:
- Publication type:
- Article
Evaluation of Continuous Tumor-Size–Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer.
- Published in:
- JAMA Network Open, 2019, v. 29, p. e1911750, doi. 10.1001/jamanetworkopen.2019.11750
- By:
- Publication type:
- Article
Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 3, p. 515, doi. 10.1007/s00280-007-0498-4
- By:
- Publication type:
- Article
Angiogenesis and angiogenic inhibitors in renal cell carcinoma.
- Published in:
- Current Urology Reports, 2008, v. 9, n. 1, p. 26, doi. 10.1007/s11934-008-0007-2
- By:
- Publication type:
- Article
Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 8, p. 1547, doi. 10.1002/cncr.27947
- By:
- Publication type:
- Article
Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 23, p. 5777, doi. 10.1002/cncr.27607
- By:
- Publication type:
- Article
Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 7, p. 1795, doi. 10.1002/cncr.26453
- By:
- Publication type:
- Article
Chromosome 9p Deletions Identify an Aggressive Phenotype of Clear Cell Renal Cell Carcinoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 20, p. 4696, doi. 10.1002/cncr.25279
- By:
- Publication type:
- Article
Histologic Evaluation of Metastases in Renal Cell Carcinoma With Sarcomatoid Transformation and Its Implications for Systemic Therapy.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 3, p. 616, doi. 10.1002/cncr.24768
- By:
- Publication type:
- Article
Cancer-specific Survival Outcomes Among Patients Treated During the Cytokine Era of Kidney Cancer (1989-2005): A Benchmark for Emerging Targeted Cancer Therapies.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 9, p. 2457, doi. 10.1002/cncr.23851
- By:
- Publication type:
- Article
Brain Metastasis From Renal Cell Carcinoma: Presentation, Recurrence, and Survival.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 7, p. 1641, doi. 10.1002/cncr.23769
- By:
- Publication type:
- Article
Performance Status and Cytoreductive Nephrectomy: Redefining Management in Patients With Poor Performance.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 6, p. 1324, doi. 10.1002/cncr.23708
- By:
- Publication type:
- Article
Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.
- Published in:
- Journal of Surgical Oncology, 2005, v. 91, n. 3, p. 173, doi. 10.1002/jso.20301
- By:
- Publication type:
- Article
Regarding 'Treatment of Colorectal Cancer with and without Bevacizumab: A Phase III Study'.
- Published in:
- Oncology, 2011, v. 80, n. 1/2, p. 135, doi. 10.1159/000327227
- By:
- Publication type:
- Article
Clinical Outcomes in Elderly Patients with Metastatic Colorectal Cancer Receiving Bevacizumab and Chemotherapy: Results from the BRiTE Observational Cohort Study.
- Published in:
- Oncology, 2010, v. 78, n. 5/6, p. 329, doi. 10.1159/000320222
- By:
- Publication type:
- Article
Bevacizumab Improves the Overall and Progression-Free Survival of Patients with Metastatic Colorectal Cancer Treated with 5-Fluorouracil-Based Regimens Irrespective of Baseline Risk.
- Published in:
- Oncology, 2008, v. 75, n. 3/4, p. 215, doi. 10.1159/000163850
- By:
- Publication type:
- Article
Bevacizumab Combined with Standard Fluoropyrimidine-Based Chemotherapy Regimens to Treat Colorectal Cancer.
- Published in:
- Oncology, 2005, v. 69, p. 17, doi. 10.1159/000088480
- By:
- Publication type:
- Article
Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 8, p. e1327, doi. 10.1002/onco.13830
- By:
- Publication type:
- Article
Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled Trials.
- Published in:
- Oncologist, 2013, v. 18, n. 9, p. 1004, doi. 10.1634/theoncologist.2013-0107
- By:
- Publication type:
- Article
Clinical Outcomes Associated with Bevacizumab-Containing Treatment of Metastatic Colorectal Cancer: The BRiTE Observational Cohort Study.
- Published in:
- Oncologist, 2009, v. 14, n. 9, p. 862, doi. 10.1634/theoncologist.2009-0071
- By:
- Publication type:
- Article
Health-Related Quality of Life Impact of Bevacizumab When Combined with Irinotecan, 5-Fluorouracil, and Leucovorin or 5-Fluorouracil and Leucovorin for Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2008, v. 13, n. 9, p. 1021, doi. 10.1634/theoncologist.2008-0003
- By:
- Publication type:
- Article
A randomized Phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small-cell lung cancer.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 7275, doi. 10.2147/OTT.S109186
- By:
- Publication type:
- Article